Intellia Therapeutics Inc Earnings

The next earnings date for Intellia Therapeutics Inc is November 6, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Intellia Therapeutics Inc Earnings

Report Date	Estimated Earnings Per Share
11/06/2025	$-1.00

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Intellia Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/07/2025	---	$-0.98	4.85%
07/31/2025	---	$0	100.00%
05/07/2025	Before Market	$-1.10	13.46%
02/20/2025	Before Market	$-1.27	3.52%
11/07/2024	Before Market	$-1.34	2.90%
08/08/2024	Before Market	$-1.52	-23.58%
05/09/2024	Before Market	$-1.12	18.84%
02/22/2024	Before Market	$-1.46	-0.69%
11/09/2023	Before Market	$-1.38	8.00%
08/03/2023	Before Market	$-1.40	-6.06%
05/04/2023	Before Market	$-1.17	16.43%
02/23/2023	Before Market	$-1.40	-0.72%
11/03/2022	Before Market	$-1.49	-16.41%
08/04/2022	Before Market	$-1.33	-1.53%
05/05/2022	Before Market	$-1.96	-78.18%
02/24/2022	Before Market	$-1.09	-15.96%
11/04/2021	Before Market	$-0.97	-15.48%
08/05/2021	Before Market	$-1.01	-60.32%
05/06/2021	Before Market	$-0.69	-4.55%
02/25/2021	Before Market	$-0.69	-15.00%
11/05/2020	Before Market	$-0.47	20.34%
08/06/2020	Before Market	$-0.61	11.59%
05/07/2020	Before Market	$-0.63	-50.00%
02/27/2020	Before Market	$-0.57	-1.79%
10/31/2019	Before Market	$-0.49	20.97%
08/01/2019	Before Market	$-0.56	6.67%
05/02/2019	Before Market	$-0.49	16.95%
02/27/2019	Before Market	$-0.43	23.21%
10/31/2018	Before Market	$-0.53	-8.16%
08/01/2018	Before Market	$-0.52	5.45%
05/01/2018	Before Market	$-0.51	12.07%
03/14/2018	Before Market	$-0.61	-45.24%
10/31/2017	Before Market	$-0.44	12.00%
08/01/2017	Before Market	$-0.45	-9.76%
05/02/2017	Before Market	$-0.36	-5.88%
03/14/2017	Before Market	$-0.31	-40.91%
11/01/2016	After Market	$-0.22	0.00%
08/04/2016	After Market	$-0.36	-260.00%
06/03/2016	After Market	$-9.89	-3,432.14%

More About Intellia Therapeutics Inc

Website

https://www.intelliatx.com

Country

USA

Full Time Employees

403

Intellia Therapeutics, Inc., a clinical-stage gene editing company, focuses on the development of curative genome editing treatments. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 that is in Phase 1/2 study for the treatment of hereditary angioedema. It also focusses on the research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. The company has license and collaboration agreement with AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of various of B cell-mediated autoimmune diseases; ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer; and ReCode Therapeutics, Inc. to develop novel genomic medicines for the treatment of cystic fibrosis. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

“Intellia Therapeutics Inc Earnings” Can Refer to the Intellia Therapeutics Inc Earnings Date

Some people say “Intellia Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Intellia Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Intellia Therapeutics Inc Stock on the Earnings Date

If you own Intellia Therapeutics Inc stock (NTLA) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Intellia Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Intellia Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Intellia Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Intellia Therapeutics Inc earnings or anything else related to the stock market.